{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:56:19Z","timestamp":1792454179207,"version":"4.5.0"},"reference-count":19,"publisher":"Massachusetts Medical Society","issue":"19","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2022,5,12]]},"DOI":"10.1056\/nejmoa2115542","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T17:01:43Z","timestamp":1652288503000},"page":"1793-1803","source":"Crossref","is-referenced-by-count":328,"title":["Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection"],"prefix":"10.1056","volume":"386","author":[{"given":"Sorana","family":"Segal-Maurer","sequence":"first","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"DeJesus","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Jurgen","family":"Stellbrink","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Castagna","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Richmond","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary I.","family":"Sinclair","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krittaecho","family":"Siripassorn","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Ruane","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mezgebe","family":"Berhe","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas A.","family":"Margot","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Dvory-Sobol","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Hyland","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Brainard","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Rhee","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared M.","family":"Baeten","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Molina","sequence":"additional","affiliation":[{"name":"From NewYork\u2013Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) \u2014 both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) \u2014 both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) \u2014 both in California; the University of Paris and the Department of Infectious Diseases, St. Louis\u2013Lariboisi\u00e8re Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Washington DC: Department of Health and Human Services (https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/guidelines-adult-adolescent-arv.pdf)."},{"key":"e_1_3_5_3_2","unstructured":"HIV drug resistance report 2019. Geneva: World Health Organization 2019 (https:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-HIV-19.21)."},{"key":"e_1_3_5_4_2","unstructured":"Surveillance of HIV drug resistance in adults receiving ART (acquired HIV drug resistance). Geneva: World Health Organization 2014 (https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/112801\/9789241507073_eng.pdf?sequence=1)."},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm522"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2443-1"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02057-20"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa060"},{"key":"e_1_3_5_9_2","unstructured":"Begley R Lutz J Rhee M et al. GS-6207 sustained delivery formulation supports 6-month dosing interval. Presented at the 23rd International AIDS Conference virtual July 6\u201310 2020 (https:\/\/programme.aids2020.org\/Abstract\/Abstract\/8533). abstract."},{"key":"e_1_3_5_10_2","unstructured":"Begley R Rhee MS West SK Corpus J Ling J German P. PK food effect and safety of oral GS-6207 a novel HIV-1 capsid inhibitor. Presented at the Conference on Retroviruses and Opportunistic Infections Boston March 8\u201311 2020 (https:\/\/www.croiconference.org\/wp-content\/uploads\/sites\/2\/posters\/2020\/1430_5_Begley_00470.pdf)."},{"key":"e_1_3_5_11_2","unstructured":"Daar E McDonald C Crofoot G et al. Dose-response relationship of subcutaneous long-acting HIV capsid inhibitor GS-6207. Presented at the Conference on Retroviruses and Opportunistic Infections Boston March 8\u201311 2020 (https:\/\/www.croiconference.org\/abstract\/dose-response-relationship-of-subcutaneous-long-acting-hiv-capsid-inhibitor-gs-6207\/)."},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.1999.01202.x"},{"key":"e_1_3_5_13_2","unstructured":"Human immunodeficiency virus-1 infection: developing antiretroviral drugs for treatment. Guidance for industry. Food and Drug Administration November 2015 (https:\/\/www.fda.gov\/media\/86284\/download)."},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/513823"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199905070-00008"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1711460"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902493"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328321823f"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709113371101"},{"key":"e_1_3_5_20_2","unstructured":"Guideline on the clinical development of medicinal products for the treatment of HIV infection. European Medicines Agency January 2017 (https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/guideline-clinical-development-medicinal-products-treatment-hiv-infection_en.pdf)."}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2115542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T19:15:56Z","timestamp":1749669356000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2115542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":19,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2022,5,12]]}},"alternative-id":["10.1056\/NEJMoa2115542"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2115542","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]}}}